Coronavirus, Rightful Anger

Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says
Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its Phase 1-2 trial showed antibody-related immune response.
Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its Phase 1-2 trial showed antibody-related immune response.Credit:Getty Images

Trump is eating dust yet again.

Jakarta: Indonesia’s state-owned pharmaceutical company Bio Farma said on Tuesday that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy. “Our clinical trial team found, within one month, that the interim data shows up to 97 per cent for its efficacy,” said Iwan Setiawan, a spokesman for Bio Farma, at a news conference.

Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says